NCT06115681已完成不适用
Demographic, Clinical Characteristics, and Treatment Outcomes Associated With Dedifferentiated Liposarcoma Patients in China
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,390
- 试验地点
- 1
- 主要终点
- Cohort 1: Overall Survival
研究概览
简要总结
This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clinical outcomes associated with the current real-world treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Cohort 1: Overall Survival
时间窗: Time from index date until the earliest record of death or end of the study period, up to 10 years.
Overall survival (OS) as an event for each patient in Cohort 1 was defined as the date of death minus the index date or the start day of each line of therapy (LOT). For patients with no record of death, OS was censored at the last activity date before the end of the study period.
次要结局
- Cohort 1, Cohort 2: Survival After Initial Diagnosis(Time from initial diagnosis until the earliest record of death or end of the study period, up to 10 years.)
- Cohort 1, Cohort 2: Total Number of Treatment Lines(At index date and during follow-up, up to 10 years.)
- Cohort 1, Cohort 2: First Line (1L) of Therapy by Treatment Type(At index date and during follow-up, up to 10 years)
- Cohort 1, Cohort 2: Second Line (2L) of Therapy by Treatment Type(At index date and during follow-up, up to 10 years)
- Cohort 1, Cohort 2: Number of Patients With Treatments Classified as Hormone Replacement Therapy(At index date and during follow-up, up to 10 years)
- Cohort 1, Cohort 2: Third Line (3L) of Therapy by Treatment Type(At index date and during follow-up, up to 10 years)
- Cohort 1, Cohort 2: Number of Patients With Treatments Classified as Concurrent Steroid Therapy(At index date and during follow-up, up to 10 years)
- Cohort 1, Cohort 2: Number of Patients With Treatments Classified as Concurrent Immunosuppressant Therapy(At index date and during follow-up, up to 10 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Pain Diabetic Peripheral Neuropathy（DPN) in ChinaDiabetic NeuropathiesNCT04456465Peking University Third Hospital1,500
尚未招募
不适用
Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver DiseaseDiagnosis ， Treatment， Genetic and Metabolic Liver DiseaseNCT05601557Sujun Zheng480
Unknown
不适用
Dyslipidemia International Survey-Chinathe Prevalence,Lipid Abnormalities,NCT01732952Chinese Society of Cardiology25,000
尚未招募
不适用
Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung CancerSmall Cell Lung CancerNCT06462105Zhou Chengzhi60
Unknown
不适用
Clinical Characteristics of Lung Cancer in ChinaLung CancerNCT05423236Shanghai Pulmonary Hospital, Shanghai, China119,785